Abstract
B-cell activating factor (BAFF) belonging to the TNF family plays an important role in the proliferation and differentiation of B cells which renders it an attractive target for autoimmune diseases. Some peptides have been designed to target BAFF for the treatment of autoimmune diseases. Our previous studies suggested that peptides TA and DX-814 had competitive bioactivities compared to the natural peptide trans-membrane activator and calcium modulator and cyclophilin ligand interactor (TACI) in different binding orientations. In this study, we carried out molecular modeling and dynamics and molecular docking calculations to explore the structural and chemical features responsible for the binding affinities of these peptides. Binding free energy calculations, mutational analyses were also conducted to validate our findings. The result showed that hydrophobic and electrostatic interactions are the dominant forces for binding. DX-814 had a similar binding orientation with BCMA in a conserved hydrophobic pocket and formed electrostatic interaction with conserved arginine residues on the BAFF surface, compared with TA which might interact with a sub-pocket of BAFF in a different orientation. These results provide a thorough understanding of the binding mode between BAFF and its peptide inhibitors at the molecular level and further guide inhibitor design.
Keywords: BAFF, BCMA, DX-814, molecular dynamics, sub-pocket, TA.
Protein & Peptide Letters
Title:Molecular Mechanism of the Affinity Interactions between BAFF and Its Peptides by Molecular Simulations
Volume: 22 Issue: 11
Author(s): Xuegang Fu, Liyan Xuan, Yuzhe Wang, Jing Wei and Jian Sun
Affiliation:
Keywords: BAFF, BCMA, DX-814, molecular dynamics, sub-pocket, TA.
Abstract: B-cell activating factor (BAFF) belonging to the TNF family plays an important role in the proliferation and differentiation of B cells which renders it an attractive target for autoimmune diseases. Some peptides have been designed to target BAFF for the treatment of autoimmune diseases. Our previous studies suggested that peptides TA and DX-814 had competitive bioactivities compared to the natural peptide trans-membrane activator and calcium modulator and cyclophilin ligand interactor (TACI) in different binding orientations. In this study, we carried out molecular modeling and dynamics and molecular docking calculations to explore the structural and chemical features responsible for the binding affinities of these peptides. Binding free energy calculations, mutational analyses were also conducted to validate our findings. The result showed that hydrophobic and electrostatic interactions are the dominant forces for binding. DX-814 had a similar binding orientation with BCMA in a conserved hydrophobic pocket and formed electrostatic interaction with conserved arginine residues on the BAFF surface, compared with TA which might interact with a sub-pocket of BAFF in a different orientation. These results provide a thorough understanding of the binding mode between BAFF and its peptide inhibitors at the molecular level and further guide inhibitor design.
Export Options
About this article
Cite this article as:
Fu Xuegang, Xuan Liyan, Wang Yuzhe, Wei Jing and Sun Jian, Molecular Mechanism of the Affinity Interactions between BAFF and Its Peptides by Molecular Simulations, Protein & Peptide Letters 2015; 22 (11) . https://dx.doi.org/10.2174/0929866522666150824145607
DOI https://dx.doi.org/10.2174/0929866522666150824145607 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transplantation of Genetically Modified Haematopoietic Stem Cells to Induce Antigen-Specific Tolerance as a Cure for Autoimmune Diseases
Current Stem Cell Research & Therapy Natural and Induced Regulatory T Cells: Targets for Immunotherapy of Autoimmune Disease and Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Polypeptide Delivery Across The Blood-Brain Barrier
Current Drug Targets - CNS & Neurological Disorders Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design The Effects of Dehydroepiandrosterone (DHEA) in the Treatment of Depression and Depressive Symptoms in Other Psychiatric and Medical Illnesses: A Systematic Review
Current Drug Targets 3D Printed Personalized Colon-targeted Tablets: A Novel Approach in Ulcerative Colitis Management
Current Drug Delivery Targeting Toll-like Receptors in Autoimmunity
Current Drug Targets Metabolic Changes in Autoimmune Diseases
Current Drug Discovery Technologies Vasculitis Following Influenza Vaccination: A Review of the Literature
Current Rheumatology Reviews Associations between Depressive Disorders and Inflammatory Rheumatic Diseases
Current Topics in Medicinal Chemistry Targeted Therapies – Many Ways to (the Peace of) Rome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus: An Update on Recent Developments
Current Diabetes Reviews The Role of Neutrophil Proteases in LPS-Induced Production of Regulatory Rheumatoid Factor that Suppresses Autoimmunity
Endocrine, Metabolic & Immune Disorders - Drug Targets Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Autoimmune Lymphoproliferative Syndrome (ALPS)
Current Pharmaceutical Design Tissue-specific Glucocorticoid Signaling May Determine the Resistance Against Glucocorticoids in Autoimmune Diseases
Current Medicinal Chemistry Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies
Current Vascular Pharmacology Modulation of Inducible Nitric Oxide Synthase Activation by Immuno-suppressive Drugs
Current Drug Metabolism NKT Cell-Stimulating Synthetic Glycolipids as Potential Therapeutics for Autoimmune Disease
Current Topics in Medicinal Chemistry Triggering of Apoptosis and Pro-Inflammatory Cytokines in NK Cells: Regulation by Cyclosporin A
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents